Pharmaceutical Regulation of Herbal Medicinal Products in the Countries of the European Union, the USA, Canada and Japan
The regulation of herbal medicines is changing and alters in the different countries. The Federal Food, Drug, and Cosmetic Act (FD&C Act) defines medicines on the grounds of their intended use. Medicines shall be preliminarily approved by the FDA prior to their placing on the market or if they a...
Main Authors: | Hadzhieva B., Dimitrov M., Petkova V. |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2023-09-01
|
Series: | Acta Medica Bulgarica |
Subjects: | |
Online Access: | https://doi.org/10.2478/amb-2023-0034 |
Similar Items
-
Marketing Channel Problems of Herbal Medicines from the Perspective of Pharmaceutical Distribution Companies
by: Ali Abedini Abedini, et al.
Published: (2020-02-01) -
The Place of the European Union Countries in the Global Pharmaceutical Market
by: Shuba Maryna V., et al.
Published: (2023-01-01) -
The Problems of Herbal Medicines Marketing Channel from the Perspective of Manufacturers: A Qualitative Study
by: Ali Abedini, et al.
Published: (2020-11-01) -
THE IMPACT OF THE EUROPEAN DIRECTIVE AGAINST FALSIFIED MEDICINES ON THE PHARMACEUTICAL WHOLESALERS IN BULGARIA
by: Krasimira Valcheva
Published: (2021-03-01) -
The effect of the European traditional use directive on the register of herbal medicinal products in Spain
by: Noelia Tejedor-García, et al.
Published: (2015-05-01)